Danish Council for Independent Research   Report issue

Government Phase 1 Phase 2 Phase 3 Phase 4
Founded: Copenhagen Denmark (2004)

Organization Overview

First Clinical Trial
2004
NCT01353807
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Danish Council for Independent Research

Active Ingredients

Drugs in Phase 4 Trials (2)

hydralazine (apresoline) (1 trial)

metformin (glucophage) (1 trial)

Drugs in Phase 3 Trials (2)

fibrinogen (human) (RiaSTAP) (1 trial)

sodium chloride (1 trial)

Drugs in Phase 2 Trials (1)

citalopram (celexa) (1 trial)

Drugs in Phase 1 Trials (1)

morphine (1 trial)

Drugs in Other Trials (4)

fish oil (Omegavan) (1 trial)

glucagon (1 trial)

high-selenium yeast (1 trial)

olive oil (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Heart Failure (Phase 4)

Hemorrhage (Phase 3)

Postpartum Hemorrhage (Phase 3)

Stroke (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 10